RLAY insider plans sale of 30,000 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RLAY reporting person Sekar Kathiresan filed to sell common stock. The planned transaction covers 30,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on or about July 31, 2026 on NASDAQ, with an indicated value of $563,553.00.
The filing also lists prior sales within three months: 30,000 shares of common stock on July 21, 2026 for $594,414.00, and 66,055 shares on July 20, 2026 for $1,293,555.07. The planned sale is linked to a stock option exercise settled in cash.
Key Figures
Key Terms
Form 144 regulatory
Stock Option Exercise financial
Executive Financial Services financial
aggregate value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What planned stock sale did RLAY filer Sekar Kathiresan disclose?
What recent RLAY stock sales are reported for Sekar Kathiresan in this Form 144?
On which exchange is the planned RLAY stock sale expected to occur?
AI-generated analysis. How Rhea-AI works. Not financial advice.